Russell Angus C.
Insider CIK 1534002 · ITMN Director · RVNC Director · MNK Director · GPCR Director · TXMD Director · BTX Director · QCOR Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2026-07-01 | 2026-07-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2026-06-17 | 2026-06-18 | 39,453 | — | $0 | 39,453 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2025-07-01 | 2025-07-02 | 75,000 | — | $0 | 75,000 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2025-06-23 | 2025-06-25 | 42,833 | — | $0 | 42,833 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 15,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 36,506 | $3.65 | $133.2K | 15,000 | SEC↗ |
| GPCR Structure Therapeutics Inc | A Award deriv | 2024-08-26 | 2024-08-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2024-07-01 | 2024-07-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 23,458 | — | $0 | 23,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-05-01 | 2024-05-03 | 15,000 | — | $0 | 51,506 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2023-07-01 | 2023-07-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 5,915 | — | $0 | 5,915 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-05-03 | 2023-05-05 | 3,534 | — | $0 | 36,506 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2022-09-29 | 2022-10-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2022-08-18 | 2022-08-22 | 1,984 | — | $0 | 0 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2022-08-18 | 2022-08-22 | 1,984 | — | $0 | 5,792 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2022-07-01 | 2022-07-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 11,343 | — | $0 | 11,343 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-13 | 10,756 | — | $0 | 10,756 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-05-04 | 2022-05-06 | 6,059 | — | $0 | 32,972 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | P Buy | 2021-12-13 | 2021-12-15 | 6,400 | $15.74 | $100.7K | 26,913 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2021-08-10 | 2021-08-12 | 96,864 | — | $0 | 0 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2021-08-10 | 2021-08-12 | 96,864 | — | $0 | 190,364 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2021-07-01 | 2021-07-01 | 50,000 | — | $0 | 50,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 99,174 | — | $0 | 99,174 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise deriv | 2021-06-29 | 2021-06-30 | 24,720 | — | $0 | 0 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | M Exercise | 2021-06-29 | 2021-06-30 | 24,720 | $2.20 | $54.4K | 92,220 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | S Sale | 2021-06-29 | 2021-06-30 | 4,720 | $2.97 | $14.0K | 87,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-05-05 | 2021-05-07 | 7,551 | — | $0 | 7,551 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-05-05 | 2021-05-07 | 4,013 | — | $0 | 20,513 | SEC↗ |
| MNKKQ Mallinckrodt plc | S Sale | 2020-11-12 | 2020-11-16 | 51,789 | $0.13 | $6.7K | 0 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2020-07-01 | 2020-07-02 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 96,864 | — | $0 | 96,864 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-05-14 | 2020-05-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-05-14 | 2020-05-15 | 6,000 | — | $0 | 16,500 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2020-05-13 | 2020-05-15 | 12,042 | $2.96 | $35.6K | 51,789 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2019-08-23 | 2019-08-26 | 10,000 | $2.77 | $27.7K | 93,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2019-08-15 | 2019-08-15 | 10,000 | $2.99 | $29.9K | 83,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2019-08-14 | 2019-08-15 | 25,000 | $2.76 | $69.0K | 73,500 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2019-07-01 | 2019-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 75,000 | — | $0 | 75,000 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2019-05-15 | 2019-05-17 | 26,759 | — | $0 | 63,831 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2019-05-15 | 2019-05-17 | 11,764 | $15.21 | $178.9K | 37,072 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-05-09 | 2019-05-10 | 9,000 | — | $0 | 9,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-05-09 | 2019-05-10 | 4,500 | — | $0 | 10,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2018-07-02 | 2018-07-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2018-07-01 | 2018-07-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2018-05-16 | 2018-05-18 | 26,141 | — | $0 | 48,836 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2018-05-10 | 2018-05-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2018-05-10 | 2018-05-11 | 3,000 | — | $0 | 6,000 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2018-03-01 | 2018-03-05 | 2,576 | $15.68 | $40.4K | 22,695 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2017-10-01 | 2017-10-03 | 476 | $37.37 | $17.8K | 25,271 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2017-07-01 | 2017-07-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2017-06-21 | 2017-06-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2017-05-11 | 2017-05-12 | 6,000 | — | $0 | 6,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2017-05-11 | 2017-05-12 | 3,000 | — | $0 | 3,000 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2017-03-01 | 2017-03-03 | 2,286 | $51.55 | $117.8K | 25,747 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2017-03-01 | 2017-03-03 | 5,723 | — | $0 | 28,033 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2016-12-21 | 2016-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2016-10-01 | 2016-10-04 | 1,057 | — | $0 | 22,310 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2016-07-21 | 2016-07-25 | 1,037 | — | $0 | 21,253 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2016-07-01 | 2016-07-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-05-05 | 2016-05-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2016-03-16 | 2016-03-18 | 4,041 | — | $0 | 20,674 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2016-03-16 | 2016-03-18 | 458 | $55.69 | $25.5K | 20,216 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2015-12-17 | 2015-12-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| BTX BIOTIME INC | P Buy | 2015-11-06 | 2015-11-10 | 50,000 | $3.83 | $191.5K | 67,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2015-08-25 | 2015-08-27 | 13,500 | $5.98 | $80.7K | 48,500 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2015-07-01 | 2015-07-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | P Buy | 2015-05-12 | 2015-05-13 | 35,000 | $6.15 | $215.3K | 35,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2015-03-25 | 2015-03-26 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2015-03-19 | 2015-03-23 | 1,893 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | F Tax w/h | 2015-03-19 | 2015-03-23 | 606 | $131.21 | $79.5K | 16,633 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2015-03-19 | 2015-03-23 | 1,715 | — | $0 | 17,239 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2015-03-19 | 2015-03-23 | 1,893 | — | $0 | 15,524 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 6,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 8,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 12,500 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer deriv | 2014-09-29 | 2014-10-01 | 4,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | D To issuer | 2014-09-29 | 2014-10-01 | 1,200 | $74.00 | $88.8K | 0 | SEC↗ |
| ITMN INTERMUNE INC | U Tender | 2014-09-29 | 2014-10-01 | 15,958 | $74.00 | $1.18M | 1,200 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2014-08-14 | 2014-11-06 | 13,631 | — | $0 | 13,631 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer deriv | 2014-08-14 | 2014-08-18 | 3,281 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | A Award deriv | 2014-08-14 | 2014-08-18 | 1,893 | — | $0 | 1,893 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-08-14 | 2014-08-18 | 3,835 | — | $0 | 0 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | D To issuer | 2014-08-14 | 2014-08-18 | 4,529 | — | $0 | 0 | SEC↗ |
| MNK Mallinckrodt plc | A Award | 2014-08-14 | 2014-08-18 | 21,530 | — | $0 | 21,530 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise deriv | 2014-05-30 | 2014-06-02 | 3,000 | — | $0 | 0 | SEC↗ |
| ITMN INTERMUNE INC | M Exercise | 2014-05-30 | 2014-06-02 | 3,000 | — | $0 | 17,158 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2014-05-29 | 2014-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-03-04 | 2014-03-06 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ITMN INTERMUNE INC | P Buy | 2013-08-27 | 2013-08-28 | 4,950 | $14.37 | $71.1K | 14,158 | SEC↗ |
| ITMN INTERMUNE INC | P Buy | 2013-08-26 | 2013-08-28 | 1,650 | $15.00 | $24.8K | 9,208 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | P Buy | 2013-06-14 | 2013-06-18 | 3,250 | $46.15 | $150.0K | 8,364 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2013-06-08 | 2013-11-13 | 11,252 | — | $0 | 11,252 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-06-08 | 2013-11-13 | 5,114 | — | $0 | 5,114 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award deriv | 2013-06-08 | 2013-06-11 | 11,252 | — | $0 | 11,252 | SEC↗ |
| QCOR QUESTCOR PHARMACEUTICALS I | A Award | 2013-06-08 | 2013-06-11 | 5,114 | — | $0 | 5,114 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2013-05-30 | 2013-06-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award deriv | 2012-06-04 | 2012-06-06 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ITMN INTERMUNE INC | A Award | 2012-06-04 | 2012-06-06 | 2,500 | $10.10 | $25.3K | 7,558 | SEC↗ |